Purus Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
3,502
-147
| -4% | -$11.5K | 0.1% | 109 |
|
|
2025
Q1 | $264K | Buy |
3,649
+60
| +2% | +$4.35K | 0.11% | 102 |
|
|
2024
Q4 | $266K | Buy |
3,589
+354
| +11% | +$26.2K | 0.11% | 99 |
|
|
2024
Q3 | $213K | Buy |
3,235
+23
| +0.7% | +$1.52K | 0.09% | 114 |
|
|
2024
Q2 | $297K | Buy |
3,212
+160
| +5% | +$14.8K | 0.13% | 91 |
|
|
2024
Q1 | $292K | Sell |
3,052
-151
| -5% | -$14.4K | 0.14% | 88 |
|
|
2023
Q4 | $244K | Buy |
3,203
+72
| +2% | +$5.49K | 0.14% | 110 |
|
|
2023
Q3 | $217K | Buy |
3,131
+68
| +2% | +$4.71K | 0.15% | 111 |
|
|
2023
Q2 | $289K | Buy |
3,063
+35
| +1% | +$3.3K | 0.19% | 90 |
|
|
2023
Q1 | $250K | Buy |
3,028
+40
| +1% | +$3.31K | 0.2% | 99 |
|
|
2022
Q4 | $223K | Buy |
2,988
+20
| +0.7% | +$1.49K | 0.2% | 99 |
|
|
2022
Q3 | $245K | Sell |
2,968
-11
| -0.4% | -$908 | 0.23% | 89 |
|
|
2022
Q2 | $283K | Buy |
2,979
+70
| +2% | +$6.65K | 0.25% | 82 |
|
|
2022
Q1 | $342K | Buy |
2,909
+1,229
| +73% | +$144K | 0.24% | 81 |
|
|
2021
Q4 | $218K | Buy |
+1,680
| New | +$218K | 0.14% | 105 |
|